Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 20.12% | -10.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.12% | -10.91% | |||
| Cost of Revenue | -13.36% | -55.76% | |||
| Gross Profit | 71.58% | 259.66% | |||
| SG&A Expenses | 17.55% | -12.29% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.42% | -17.79% | |||
| Operating Income | -14.85% | 18.61% | |||
| Income Before Tax | -758.99% | 5.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -758.99% | 5.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -758.99% | 5.90% | |||
| EBIT | -14.85% | 18.61% | |||
| EBITDA | -14.97% | 18.69% | |||
| EPS Basic | -400.00% | 0.00% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -400.00% | 0.00% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.69% | 1.70% | |||
| Average Diluted Shares Outstanding | 0.69% | 1.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||